News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Industry News Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events November 02, 2016
Presentation TCT 2016 Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations Presenter: Aaron V. Kaplan, Rachel Neubrander, Tamara Syrek Jensen November 01, 2016
Presentation TCT 2016 Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives Presenter: Aaron V. Kaplan, Rachel Neubrander, Brian K. Whisenant November 01, 2016
Presentation TCT 2016 Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See Presenter: Aaron V. Kaplan, Rachel Neubrander, Katherine Wallon November 01, 2016
Presentation TCT 2016 The Tricuspid Valve: Challenges for Clinical Investigation Presenter: Matthew G. Hillebrenner, Michael J. Mack, Rebecca T. Hahn November 01, 2016
Presentation TCT 2016 Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Gregg W. Stone November 01, 2016
Presentation TCT 2016 Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies Presenter: Matthew G. Hillebrenner, Michael J. Mack, John C Laschinger November 01, 2016
Presentation TCT 2016 Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons, Neuroprotection Systems, and More) Presenter: Nicole Ibrahim, Martin B. Leon November 01, 2016
Presentation TCT 2016 Valve Degeneration and Mobility Considerations: Assessing Clinical Relevance Presenter: Nicole Ibrahim, Martin B. Leon, Raj Makkar November 01, 2016
News Industry News TCT 2016 Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke November 01, 2016
Presentation TCT 2016 FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben November 01, 2016
News Conference News TCT 2016 Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention Yael L. Maxwell November 01, 2016
News Industry News Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance November 01, 2016
News Industry News Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients November 01, 2016
News Industry News TCT 2016 Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement November 01, 2016